Vireo Growth Inc (VREOF) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

contain forward-looking statements within the meaning of U.S. and Canadian securities laws. These statements are based on management's current expectations and involve risks and uncertainties that could differ materially from actual events and those described in such forward-looking statements. For more information on forward-looking statements, please refer to cautionary note regarding forward-closing statements. in the company's earnings release. I'll now hand the call over to Chief Executive Officer John Mareskis. Please go ahead. Thank you. Good morning, everyone. I'll begin with a brief summary of Q3 and recent business highlights, then Tyson will provide some extra detail on the financials before we open the call to questions. Our third quarter results reflect our first full quarter of contributions from our recently closed M&A transaction in Missouri, Nevada, and Utah. Performance remains in line with our expectations and reflected organic growth throughout the portfolio in addition to the growth realized from the acquisitions. Subsequent to quarter end, we announced the acquisition of 86% of the outstanding senior secured convertible notes of U.S. multi-state cannabis operator, SWAS. We've entered into a restructuring support agreement with Suaz, which once completed, will result in Vireo owning the majority of Suaz's total assets. Today, the Suaz portfolio includes 46 dispensaries and two manufacturing facilities spread across Colorado and New Mexico, which would expand Vireo's portfolio to eight states with more than 80 operating dispensaries. As is the case with our portfolio acquisition, the Colorado and New Mexico assets, represent leading businesses within their respective markets. As we have stated in the past, we are seeking to build a portfolio of pr...